Cargando…

Cell-Based Regeneration and Treatment of Liver Diseases

The liver, in combination with a functional biliary system, is responsible for maintaining a great number of vital body functions. However, acute and chronic liver diseases may lead to irreversible liver damage and, ultimately, liver failure. At the moment, the best curative option for patients suff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofmann, Julia, Hackl, Verena, Esser, Hannah, Meszaros, Andras T., Fodor, Margot, Öfner, Dietmar, Troppmair, Jakob, Schneeberger, Stefan, Hautz, Theresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508969/
https://www.ncbi.nlm.nih.gov/pubmed/34638617
http://dx.doi.org/10.3390/ijms221910276
_version_ 1784582223699116032
author Hofmann, Julia
Hackl, Verena
Esser, Hannah
Meszaros, Andras T.
Fodor, Margot
Öfner, Dietmar
Troppmair, Jakob
Schneeberger, Stefan
Hautz, Theresa
author_facet Hofmann, Julia
Hackl, Verena
Esser, Hannah
Meszaros, Andras T.
Fodor, Margot
Öfner, Dietmar
Troppmair, Jakob
Schneeberger, Stefan
Hautz, Theresa
author_sort Hofmann, Julia
collection PubMed
description The liver, in combination with a functional biliary system, is responsible for maintaining a great number of vital body functions. However, acute and chronic liver diseases may lead to irreversible liver damage and, ultimately, liver failure. At the moment, the best curative option for patients suffering from end-stage liver disease is liver transplantation. However, the number of donor livers required by far surpasses the supply, leading to a significant organ shortage. Cellular therapies play an increasing role in the restoration of organ function and can be integrated into organ transplantation protocols. Different types and sources of stem cells are considered for this purpose, but highly specific immune cells are also the focus of attention when developing individualized therapies. In-depth knowledge of the underlying mechanisms governing cell differentiation and engraftment is crucial for clinical implementation. Additionally, novel technologies such as ex vivo machine perfusion and recent developments in tissue engineering may hold promising potential for the implementation of cell-based therapies to restore proper organ function.
format Online
Article
Text
id pubmed-8508969
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85089692021-10-13 Cell-Based Regeneration and Treatment of Liver Diseases Hofmann, Julia Hackl, Verena Esser, Hannah Meszaros, Andras T. Fodor, Margot Öfner, Dietmar Troppmair, Jakob Schneeberger, Stefan Hautz, Theresa Int J Mol Sci Review The liver, in combination with a functional biliary system, is responsible for maintaining a great number of vital body functions. However, acute and chronic liver diseases may lead to irreversible liver damage and, ultimately, liver failure. At the moment, the best curative option for patients suffering from end-stage liver disease is liver transplantation. However, the number of donor livers required by far surpasses the supply, leading to a significant organ shortage. Cellular therapies play an increasing role in the restoration of organ function and can be integrated into organ transplantation protocols. Different types and sources of stem cells are considered for this purpose, but highly specific immune cells are also the focus of attention when developing individualized therapies. In-depth knowledge of the underlying mechanisms governing cell differentiation and engraftment is crucial for clinical implementation. Additionally, novel technologies such as ex vivo machine perfusion and recent developments in tissue engineering may hold promising potential for the implementation of cell-based therapies to restore proper organ function. MDPI 2021-09-24 /pmc/articles/PMC8508969/ /pubmed/34638617 http://dx.doi.org/10.3390/ijms221910276 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hofmann, Julia
Hackl, Verena
Esser, Hannah
Meszaros, Andras T.
Fodor, Margot
Öfner, Dietmar
Troppmair, Jakob
Schneeberger, Stefan
Hautz, Theresa
Cell-Based Regeneration and Treatment of Liver Diseases
title Cell-Based Regeneration and Treatment of Liver Diseases
title_full Cell-Based Regeneration and Treatment of Liver Diseases
title_fullStr Cell-Based Regeneration and Treatment of Liver Diseases
title_full_unstemmed Cell-Based Regeneration and Treatment of Liver Diseases
title_short Cell-Based Regeneration and Treatment of Liver Diseases
title_sort cell-based regeneration and treatment of liver diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508969/
https://www.ncbi.nlm.nih.gov/pubmed/34638617
http://dx.doi.org/10.3390/ijms221910276
work_keys_str_mv AT hofmannjulia cellbasedregenerationandtreatmentofliverdiseases
AT hacklverena cellbasedregenerationandtreatmentofliverdiseases
AT esserhannah cellbasedregenerationandtreatmentofliverdiseases
AT meszarosandrast cellbasedregenerationandtreatmentofliverdiseases
AT fodormargot cellbasedregenerationandtreatmentofliverdiseases
AT ofnerdietmar cellbasedregenerationandtreatmentofliverdiseases
AT troppmairjakob cellbasedregenerationandtreatmentofliverdiseases
AT schneebergerstefan cellbasedregenerationandtreatmentofliverdiseases
AT hautztheresa cellbasedregenerationandtreatmentofliverdiseases